599
255608226014562122
Ces38177936014570127174
Urol40167936014578115180208
2022;42497936014562121178238261
26(1):45367936014561119152206230252
13–2848147936014561113174229288
PŘEHLEDOVÉ3674207016974156235334409485586692777855
ČLÁNKY4568207016989162260360444533
51.624896013356107124
You772896013358111172
D,96789601337291
Jeong108289601333995156216278
IG,138389601332596120
Song1527896013353113174235
C,178589601336387
et189689601335490
al.200989601335278100
Analysis2133898013163121170192240281302341
of249889801315786
pre‑operative260889801315991143177238298352384434466488537589
variables322189801314998130152200260283336376
for362189801312885117
identifying376289801312281134192224246274327350407466
patients4253898013159109141163216274305347
who4624898013178137195
might4843898013189111170228260
benefit6241048013161115173226251278311
from959104801312760117206
upfront11891048013156116144177234292324
cytoreductive1537104801314798135191223275335392441477499548600
nephrectomy21611048013157110170228260311361397453542589
for2774104801312684116
metastatic29141048013188141174223263298347379402450
renal3388104801313082140188211
cell3623104801314797120142
carcinoma3789104801314797128175196254312402451
in4264104801312178
the4366104801313290143
targeted4533104801313282113171224257308368
the‑4925104801313290143178
rapy624119801313282142189
era.837119801315485135154
Jpn1015119801313898156
J11951198013138
Clin1257119801316385106164
Oncol.14451198013174133181237260279
2015;17481198013154105153198212
45(1):19841198013154103129177197214
96–102.22221198013153107165211258308326
doi:10.1093/jjco/hyu171.257211980131601181401572012482663123594134624985225465946506877467928518969399881001
52.6241346013356110132
Fukuda7801346013360117168229291343
H,11461346013379102
Takagi12711346013362107158211273298
T,1592134601336177
Kondo16921346013367125186248308
T,2023134601336277
et2124134601336198
al.2245134601336085107
Prognostic2376134801316293149209267325365400422470
value28701348013157107129186239
of3133134801316594
the3251134801314199152
Glasgow3427134801317599147187246304383
Prognostic3834134801316292149209267325365400422470
Score43281348013158107163195246
for4598134801313693125
patients47471348013168118150172225282314356
with6241498013179102135193
metastatic8411498013193146179229268303352385407455
renal1320149801313586144193215
cell15591498013151102125146
carcinoma17291498013152101133179201259317406455
treated2208149801313768120168200251311
by25431498013163110
cytoreductive26771498013152102140196228279340397445481503553605
nephrectomy.33061498013161114173232263315364400456546592605
Int3935149801312683115
J40741498013140
Clin4138149801316587109166
Oncol.43281498013176135184240263281
2018;46331498013156107155202219
23(3):48761498013156108135185210227
539–546.6241648013154103154211262316370390
doi:10.1007/s10147-017-1221-z.103816480131591181401572012482663123594144634925285736206687147637908468949389651011105511081155118212221242
53.6241796013356107128
Marchioni7741796013383135169216274298357416440
M,12371796013383106
Kriegmair1365179601335591115169229318369393427
M,18151796013383106
Heck19431796013367121169218
M,21841796013383106
et2312179601335086
al.242017960133487394
Development25371798013166118165216237294353440492548579
of3139179801315481
a32431798013145
Novel33111798013165122169219241
Risk3575179801315172110154
Score3752179801314694148179229
to4004179801312984
Select4111179801314698120171219254
the4388179801313086138
Optimal45491798013168127159180267315336
Can‑49081798013157106162194
didate624194801315981139187219269
for916194801312581113
Cytoreductive1052194801315999136191223274333389437473494543594
Nephrectomy16691948013166119177235266317365401456545590
Among22831948013160148205263322
Patients2628194801315198130152203260292333
with2984194801317597130187
Metastatic31951948013181133166215254288336368390437
Renal36561948013151103160208230
Cell39101948013158108130152
Carcinoma.40851948013158107138184205262320408456475
Results45841948013151103143199220253294
from4901194801312557113202
a6242098013150
Multi‑institutional6982098013181138160193215248271328368402424457514548570627685734756
Registry14782098013151104164186224259290342
(REMARCC).1844209801312579130214278332394451482497
Eur23642098013148103134
Urol2522209801316595151174
Oncol.27202098013170129177233256274
2021;30182098013150101150197207
4(2):3249209801315078129155172
256–263.34452098013150102154211258309360377
doi:10.1016/j.euo.2020.38462098013156114136153197244261307354401448485508527579636694712766817867918936
12.4806209801314994111
010.4941209801315097144162
54.6242246013356111133
Kutikov7792246013355113148172222280330
A,1132224601336286
Uzzo12412246013366111160218
RG,14822246013354124147
Caraway16522246013359111145197275327376
A,2050224601336387
et2159224601335187
al.226822460133497395
Use23862248013164101153
of2563224801315381
systemic2668224801313684124158208295317364
therapy3055224801313087139169218277323
and34022248013145102160
factors3585224801312574122157212244284
affecting3892224801314574103154203238259316374
survival4289224801313792123175197245294316
for4628224801312581112
patients47632248013156105137158210266297338
undergoing6242398013158114172223254310367388445503
cytoreductive1150239801314494130184215266324380427462484532582
nephrectomy.17552398013154106164222252302350385440528573585
BJU2363239801315186153
Int.2539239801311975106124
2009;2686239801314999153205222
106(2):2931239801314995148175225250266
218–223.3220239801314995140195241292344361
doi:10.1111/j.1464-410X.2009.09079.x.36042398013155111133149192238255300339379418449472490535580633688721775819865921940993104410971149116412161268132113691418143214801499
55.6242546013356109130
Culp7772546013361119144206
SH,10062546013352122146
Tannir1175254601335297157218243278
NM,14762546013370158182
Abel16812546013365127183208
EJ,1913254601335194115
et2051254601335389
al.216425460133507598
Can22852548013160110167
we24772548013176128
better26292548013158112145182233264
select2917254801313992114167217253
patients31942548013158108140162215272304346
with3564254801317799132191
metastatic37792548013187140173223263297347379401449
renal4252254801313081139188210
cell4486254801314798120142
carcinoma4652254801314696127174196253311401450
for624269801312986118
cytoreductive7662698013149100137193225277337394443479501550602
nephrectomy?13922698013159112172231262313363399455545591626
Cancer.20422698013162112170218269301315
2010;23812698013153105153200218
116(14):2623269801315495141169217263288305
3378–3388.29522698013154104152202259307357409463482
doi:10.1002/cncr.25046.34582698013160118140157202249267313360415464504547605654685699754807859914969988
56.6242846013356112134
Bamias7822846013364117208233286328
A,1133284601337297
Tzannis1253284601336099153214274299342
K,1618284601336490
Papatsoris17312846013363115176230265309369405431473
A,2228284601337196
et2347284601336097
al.2467284601335883105
Prognostic2596284801316091147207265323363398420468
Significance3088284801315677136194216242268317366424473524
of3636284801316391
Cytoreductive37522848013167108146202234285345402451487509559610
Nephrectomy43872848013174128187246277329378414470560606
in5017284801312885
Patients6242998013155103135158210268300341
With9902998013188111144203
Synchronous1217299801314893152201259290346405463521560
Metastases18012998013184137170220259294344383436477
From2302299801314877134223
Renal25502998013153106164213235
Cell28092998013161112134156
Carcinoma29892998013161110142188210268326416464
Treated3478299801314973125173205256316
With38182998013188112145203
First‑Line4045299801314971102143177206256278336389
Sunitinib:44582998013149106164185219241298320379397
A48792998013162
Eu‑49652998013149105138
ropean624314801313289148202250307
Multiinstitutional9553148013182139161194216237294333368389422480513535592650699721
Study.1700314801314778135194242255
Clin1979314801315981102159
Genitourin21623148013165118176197230286344375397454
Cancer.26403148013159108166214265296309
2014;29733148013150101149195211
12(5):3208314801315094119169196212
373–383.3444314801315098149204253304355373
doi:10.1016/j.clgc.2014.38413148013156113135152196243261306353400447484507526574596654703722776827875921938
03.48033148013150100117
012.4944314801315097141159
57.6243296013356110121
Zhao7683296013367126179239
Z,1030329601336689
Wu11423296013399157
W,13223296013398116
Duan14613296013379140192253
X,1737329601336892
Zeng18523296013366120181242
G,21173296013377101
Liu2241329601335782142
Y.2406329601336580
The25103298013157117170
value27043298013155105127184237
of2965329801316492
cytoreductive30813298013155106143199231283343400449485507556608
nephrectomy37133298013165118177236267319368404460550596
on43333298013164123
the4480329801313997151
survival46553298013146103134187210259309331
of5010329801316492
metastatic6243448013190143176226266300350382404452
renal1100344801312980138187209
carcinoma1333344801314696127173195253311401449
patients18063448013158107140162214272304346
based21763448013157107146199260
on24603448013155113
the2597344801313089142
number27633448013155112201260314346
of3133344801315583
site‑specific324034480131385992143178218277331381402428455503
metastases.37673448013187140173223262297347386439480499
Kimple4290344801315175164223246299
RJ,4613344801315293110
ed.47473448013150110128
PLoS4900344801315198155203
One.6243598013174133186203
2019;8513598013154105153198216
14(4):10913598013154100129179204221
e0215861.13363598013153107157204249300354399412
doi:10.1371/journal.pone.0215861.177235980131601181401572012482663123574054544865095676256567157647868058669259831036105311071156120312481300135313991411
58.6243746013356111134
Choueiri7823746013360119179240294320355380
TK,11853746013351111136
Xie1344374601336084139
W,15063746013390107
Kollmannsberger16363746013356115141165256308368429471532588623684739774
C,2433374601336185
et2541374601335188
al.265237460133497497
The27723748013147107160
Impact29563748013120108168217266302
of3282374801315583
Cytoreductive33893748013159100137193225276336393442478500549600
Nephrectomy40133748013167120179238269320369405461551597
on46343748013154113
Survival47713748013147103135187210259309331
of624389801315987
Patients7353898013156105137159211269301343
With11023898013191115148206
Metastatic13323898013187140173223263297347379401449
Renal18053898013157110168217239
Cell20683898013164115138159
Carcinoma22523898013163113144191213270329418467
Receiving27433898013157110160211232282304362421
Vascular31883898013158105144193251273321353
Endothelial35653898013152109169227259317370393415463485
Growth40743898013170102159237274332
Factor4430389801315296145181237269
Targeted4723389801315294125183236269320380
Therapy.6244048013151111164196245305352366
J10144048013138
Urol.1076404801316999156179197
2011;12984048013153105152193204
185(1):15264048013153100151177225245261
60–66.18124048013153107165222276295
doi:10.1016/j.juro.2010.21314048013160118141158202249267313360408454492515534557614646702720775826874921939
09.30944048013154107122
012.32404048013154102146164
59.6244196013356106125
Conti7714196013359116175209233
SL,1027419601334998121
Thomas11704196013350110169258309351
I‑C,1543419601332256122145
Hagedorn17114196013366118177231292351385445
JC,2178419601333699122
et2322419601335186
al.243041960133487394
Utilization2547419801316395117138158201250281302359416
of2986419801315381
cytoreductive3090419801314493130184215265324380427462483531582
nephrectomy36954198013154105163221251301349384439526571
and42894198013145101159
patient44724198013155104135156207264294
survival4790419801313691121172194242291312
in624434801312381
the729434801313492145
targeted898434801313483115173225259310370
therapy1292434801313492145176226286333
era.1649434801315485135154
Int1827434801312381113
J19644348013138
Cancer.20264348013163112170219270301315
2014;23654348013154105153200216
134(9):2605434801315499152181230256273
2245–2252.29024348013154106154204259306359412462479
doi:10.1002/ijc.28553.34054348013160118141158202249267313360415465505528550598617672723774823873891
60.6244496013356113135
Abern7824496013375137193229290
MR,10954496013396155180
Scosyrev12994496013361111169212265301355407
E,1730449601336184
Tsivian1837449601336398123176201254314
M,21744496013396120
et2318449601336399
al.2440449601336186109
Survival25724498013159116147200223272322344
of2940449801316795
patients30594498013169119151173225283315357
undergoing34404498013166124183236268326384406464523
cytoreductive39874498013157108145201233285345402451487509558610
surgery46214498013149106137195248279331
for4976449801313794126
metastatic6244648013190143176226266300350382404452
renal1100464801313183141189212
cell1336464801314798121142
carcinoma1502464801314898129176197255313403452
in1978464801312179
the2081464801313290143
targeted‑therapy2248464801313382114172225258309369402435493547578628687735
era.3007464801315183133152
Anticancer31834648013163121153175223273330379430461
Res.36684648013154107148167
2014;38594648013152104152198215
34(5):40984648013152106134185212228
2405–2411.4351464801315299154206261308356401442455
http://4830464801315789125185203243273
www.ncbi.nlm.nih.gov/pubmed/24778051.624479801317916224425931836642644846752654863765571573679481387293097810121069112811871277133013901430148315301578163116811735178618331845
61.6244946013356106123
Hanna7704946013373126186247299
N,1092494601337397
Sun12124946013355115175
M,14104946013390113
Meyer15474946013389145195249285
CP,18554946013365122131
et2010494601335692
al.2125494601335480102
Survival22514948013152109140193216265315337
Analyses26124948013166124172195243283336376
of3013494801315987
Patients31254948013156104136158211268300342
With34914948013191115148206
Metastatic37214948013187140173223262297347379401449
Renal41944948013157110168217239
Cancer44574948013163113171220270302
Treated4783494801315277128176208259320
With6245098013190114147205
Targeted853509801314990121179232265316376
Therapy12545098013148108161192242302349
With16275098013188111144202
or1854509801315587
Without19655098013188111145203261319352
Cytoreductive23425098013160101138194226278338395444480502551603
Nephrectomy:29695098013167121180239270322371407463553599618
A36125098013161
National36975098013168117149171229287336358
Cancer40795098013160110168216267299
Data44025098013168117149199
Base46255098013152102142195
Study.4844509801314980137197245259
J6245248013138
Clin686524801316385106164
Oncol.8745248013174132181237260278
2016;11775248013153105152199216
34(27):14185248013153107136187237266282
3267–3275.17245248013154103154203252301349399448465
doi:10.1200/JCO.2016.22135248013160118140158202249267313357409464500531593662679733785833879898
66.31355248013154108127
7931.32865248013154104154200212
62.6245396013356110133
Mathieu7805396013385138174234259313374
R,1177539601335580
Pignot1281539601335579139200260295
G,1600539601336791
Ingles1714539601332384145170225268
A,2005539601336489
et2117539601335188
al.222853960133497597
Nephrectomy23495398013167120179238269320370406462551598
improves29715398013119108167199256304355396
overall33915398013155103155186236258280
survival3695539801313793125178200250299321
in4041539801311976
patients41415398013158107140162214272304345
with4510539801317699132190
metasta‑47245398013186139172222262296346379
tic624554801313456104
renal752554801313384142191213
cell9895548013149100123145
carcinoma1158554801314998130176198256314404453
in1635554801312380
cases1739554801314999139192232
of1995554801315987
favorable2106554801312980127184216266326349402
MSKCC25325548013185135188247305
or2861554801315890
ECOG29755548013152113182251
prognostic3250554801316193150210268326366400422471
features.3745554801312981129161219250302342361
Urol41305548013169100157180
Oncol43345548013174132181237260
Semin46185548013151104193215273
Orig49155548013174106129188
Investig.624569801312381128180220255277336354
2015;10035698013153105152197212
33(8):12395698013154103130181207224
339.e9–339.e15.14875698013153103153168221274331380429479495547592636653
doi:10.1016/j.urolonc.2015.21645698013160118140157202249267313360407454492515534591622679702760818867886941992104010851101
05.32905698013153105122
014.34365698013153101148165
63.6245846013357112134
de7825846013370126
Groot9325846013379116176238274
S,1230584601336285
Redekop13395846013367123187242294354417
WK,178058460133101162188
Sleijfer1991584601336389144170196228284320
S,2335584601336386
et24445846013364101
al.2568584601336288110
Survival27025848013160117149203226276326349
in3076584801313189
Patients31905848013164112145167221279312354
With356858480131100123157216
Primary3809584801316394117207257288341
Metastatic41745848013195149182233273308358391413462
Renal46615848013164118176226249
Cell49345848013172123146168
Carcinoma6245998013163112144190212270328418467
Treated1115599801315782134182214265325
With14645998013197120154212
Sunitinib17005998013158114172194227249307328388
With21125998013197120154212
or2348599801316597
Without24695998013197120154212270328361
Previous2854599801316293144193216273331371
Cytoreductive32495998013169110148204236287348405453489511561613
Nephrectomy:38865998013176130189248279331380416472562608627
Results45385998013162115155211234267308
From4871599801315786142232
a6246148013150
Population‑based6986148013155111171229251300332354412470504565615655708768
Registry.14906148013156109169191230264296348361
Urology.18756148013169100157180238298347360
2016;22596148013154105153200217
95:25006148013154105120
121–127.2645614801315398145194240285335342
doi:10.1016/j.urology.2016.30116148013160118140157201248266312359407454491515533590622678701759820868882936988103610821101
04.41366148013154109127
042.42876148013154109158176
64.6246296013356115137
Palumbo7846296013357109134194285347408
C,1215629601336286
Mistretta13256296013387113155192227282318357410
FA,17586296013352113138
Knipper19196296013359121146208270326361
S,2304629601335275
et2402629601335491
al.251662960133517799
Contemporary26396298013161117176208259348407467499548580632
Cytoreductive32956298013161102140196228279339396445481503553604
Nephrectomy39236298013169122182241272323373409465555601
Provides4548629801315484141189212271324364
Sur‑49366298013150107138166
vival624644801315073122172194
Benefit8426448013154108166219244271304
in1170644801312280
Clear‑cell1274644801316284137185216245296347369391
Metastatic16896448013185138171221260295344377399447
Renal21606448013155108166214237
Cell24216448013161112135157
Carcinoma.26026448013161111142189211269327416465484
Clin3110644801316284105163
Genitourin32976448013168122180201235291349380402460
Cancer.37816448013162111169218269300314
2020;41196448013153104154205224
18(6):4367644801315399127177204220
e730–e738.46116448013153102154206264320369420472492
doi:10.1016/j.clgc.2020.6246598013160118140157202249267313360407454491515534582604663712731786837887938956
05.16046598013154105122
009.17506598013154109162177
65.6246746013356111132
Warren77967460133101151186222277338
M,11406746013396120
Venner12836746013370120181241297332
PM,16396746013366152176
North18386746013380141177216276
S,2137674601336285
et22456746013363100
al.2368674601336186108
A25006748013172
population‑based25976748013168127188246268317349371429487521582632672725785
study3406674801314984142201249
examining36796748013162110159248270327349407466
the41696748013142100153
effect4346674801316291121173222258
of4628674801316795
tyrosine4747674801314294126183223244302355
kinase624689801314770128177217270
inhibitors918689801313087145167226249282338370411
on13536898013166124
survival15016898013148105136189212261311333
in1858689801313088
metastatic19706898013197150183233272307356389411459
renal2453689801313991149198220
cell26976898013156107129151
carcinoma28726898013156106137184206263322411460
in3356689801313088
Alberta3468689801317194153207238275325
and38176898013157115174
the4015689801314199152
role4191689801314096119172
of4387689801316694
nephrectomy45056898013166119179238269320370406462552598
prior624704801316193115173205
to853704801313490
treatment.967704801313466117166198287340398430449
Can14407048013163113170
Urol16347048013169100157180
Assoc18387048013164106146204254
J.2116704801313855
2013;21957048013154106153198214
3(4):2433704801315480130155171
281.26297048013153104152165
doi:10.5489/cuaj.1121.28187048013159118140157201248266320373428480514557615663686704750791835883895
66.6247196013356114136
Kroeger784719601336198158213275330366
N,1173719601337497
Xie1294719601336489144
W,14617196013395112
Lee15977196013353108163
J‑L,1784719601334278132155
et1962719601335794
al.2079719601335580102
Metastatic22057198013187141174223263298347379401450
non‑clear26797198013161119177211262284337385416
cell31197198013151102124146
renal3289719801313486144193215
cell35287198013151102124146
carcinoma36987198013151100132178200258316406455
treated4177719801313567119167199250310
with45117198013181104137195
targeted4730719801313686117175228261312372
therapy624734801313492145176226285332
agents:9807348013146105158215247289306
Characterization13107348013159116165196246294330381412435478529561583640698
of2032734801315583
survival2139734801313794125177200249299321
outcome24847348013155112146192247337390
and28987348013146103162
application30847348013146106166189210258308340362419478
of3585734801315583
the3692734801313088141
International3857734801312077109159191249298330352409468516538
mRCC44197348013186141203260
Database47037348013167116148197257307346399
Consortium6247498013163119177217275307344366423512
criteria.1160749801314980103136187219241290309
Cancer.14937498013162112170219269301315
2013;18327498013154105153197213
119(16):2069749801315495140168216262289305
2999–3006.23987498013154106159213270319371426480499
doi:10.1002/cncr.28151.29217498013160118141158202249267313360415465505548606654686700755805853898945957